Smith T, Engelbrecht L, Smith C
Department Physiological Sciences, Science Faculty, Stellenbosch University, Stellenbosch, South Africa.
Central Analytical Facility, Stellenbosch University, Stellenbosch, South Africa.
J Inflamm (Lond). 2018 Jan 5;15:2. doi: 10.1186/s12950-017-0177-0. eCollection 2018.
In vivo studies have shown grape seed-derived polyphenols (GSP) to benefit in recovery from muscle injury by modulation of neutrophil infiltration into damaged tissue, thereby reducing secondary damage, as well as by facilitating an early anti-inflammatory macrophage phenotype shift. The current study aimed to provide data in this context from human models and to elucidate specific molecular targets of GSP.Using a placebo-controlled, double-blind study design, eighteen normally healthy volunteers between the ages of 18-35 years old (13 female and 5 male) were orally supplemented with 140 mg/day of GSP for 2 weeks.Blood samples (days 0 and 14) were comprehensively analysed for in vitro neutrophil chemokinetic capacity towards a chemotaxin (fMLP) using a novel neutrophil migration assay, in combination with live cell tracking, as well as immunostaining for neutrophil polarisation factors (ROCK, PI3K) at migration endpoint. Macrophage phenotype marker expression was assessed using flow cytometry.
fMLP induced significant chemokinesis ( < 0.01), validating our model. GSP did not exert a significant effect on neutrophil chemokinesis in this non-compromised population, but tended to decrease overall ROCK expression in fMLP-stimulated neutrophils ( = 0.06). Macrophage phenotype markers CD274 and MPO - indicators of a pro-inflammatory M1 phenotype - seemed to be normalised relative to baseline expression levels after GSP treatment.
Current data suggest that GSP may have a modulatory effect on the ROCK-PI3K-PTEN system, but results in this normal population is not conclusive and should be confirmed in a larger, more inflamed population. Potential modulation of macrophage phenotype by GSP should be investigated further.
体内研究表明,葡萄籽衍生的多酚(GSP)可通过调节中性粒细胞向受损组织的浸润来促进肌肉损伤的恢复,从而减少继发性损伤,还可通过促进早期抗炎巨噬细胞表型转变发挥作用。本研究旨在从人体模型中获取这方面的数据,并阐明GSP的特定分子靶点。
采用安慰剂对照、双盲研究设计,18名年龄在18 - 35岁之间的正常健康志愿者(13名女性和5名男性)口服补充140毫克/天的GSP,持续2周。
采集血液样本(第0天和第14天),使用新型中性粒细胞迁移试验结合活细胞追踪,全面分析体外中性粒细胞对趋化因子(fMLP)的化学运动能力,并在迁移终点对中性粒细胞极化因子(ROCK、PI3K)进行免疫染色。使用流式细胞术评估巨噬细胞表型标志物的表达。
fMLP诱导了显著的化学运动(<0.01),验证了我们的模型。在这个未受损的人群中,GSP对中性粒细胞化学运动没有显著影响,但倾向于降低fMLP刺激的中性粒细胞中ROCK的总体表达(=0.06)。巨噬细胞表型标志物CD274和MPO(促炎M1表型的指标)在GSP治疗后相对于基线表达水平似乎恢复正常。
目前的数据表明,GSP可能对ROCK - PI3K - PTEN系统具有调节作用,但在这个正常人群中的结果并不确凿,应在更大、炎症更严重的人群中得到证实。GSP对巨噬细胞表型的潜在调节作用应进一步研究。